SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193805-18-000177
Filing Date
2018-02-13
Accepted
2018-02-13 11:39:20
Documents
13

Document Format Files

Seq Description Document Type Size
1 e617686_sc13da-at.htm SC 13D/A 26475
2 e617686_ex-d.htm EX-99.D 183818
3 GRAPHIC image009.jpg GRAPHIC 10612
4 GRAPHIC image010.jpg GRAPHIC 15854
5 GRAPHIC image012.jpg GRAPHIC 13097
6 GRAPHIC image014.jpg GRAPHIC 12490
7 GRAPHIC image001.jpg GRAPHIC 3359
8 GRAPHIC image002.jpg GRAPHIC 46499
9 GRAPHIC image003.jpg GRAPHIC 2961
10 GRAPHIC image005.jpg GRAPHIC 76598
11 GRAPHIC image006.jpg GRAPHIC 76698
12 GRAPHIC image007.jpg GRAPHIC 174565
13 GRAPHIC image008.jpg GRAPHIC 38542
  Complete submission text file 0001193805-18-000177.txt   862241
Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 858-900-2660
Arcturus Therapeutics Ltd. (Subject) CIK: 0001566049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87471 | Film No.: 18600968
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address
Payne Joseph E (Filed by) CIK: 0001727315 (see all company filings)

Type: SC 13D/A